ANI Pharmaceuticals, Inc. (ANIP)
81.78
+0.36
(+0.45%)
USD |
NASDAQ |
May 27, 16:00
81.78
0.00 (0.00%)
After-Hours: 16:33
ANI Pharmaceuticals Cash from Investing (Quarterly) : -11.32M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Liquidia Corp. | -2.83M |
| Indivior Pharmaceuticals, Inc. | -19.00M |
| Phathom Pharmaceuticals, Inc. | -0.061M |
| Catalyst Pharmaceuticals, Inc. | -0.027M |
| Assertio Holdings, Inc. | 15.11M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 58.38M |
| Cash from Financing (Quarterly) | -21.62M |
| Free Cash Flow | 182.81M |
| Free Cash Flow Per Share (Quarterly) | 2.184 |
| Free Cash Flow to Equity (Quarterly) | 61.57M |
| Free Cash Flow to Firm (Quarterly) | 52.59M |
| Free Cash Flow Yield | 10.55% |